AZRX - AzurRx BioPharma Inc
Previous close
3.52
0 0%
Share volume: 0
Last Updated: Wed 22 Sep 2021 06:00:00 AM CEST
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$3.52
0.00
0.00%
Summary score
48%
Profitability
49%
Dept financing
19%
Liquidity
6%
Performance
65%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-74.81%
Return on assets
-38.11%
Return on sales
0%
Return on invested capital
-27.08%
Total debt ratio
76.78%
Debt ratio change over timeo
-0.5%
Current Ratio
1.16%
Quick Ratio
0%
Cash Position Ratio
0.7%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
64.29%
Return on assets
-32.04%
Return on sales
0%
Return on invested capital
35.2%
Total debt ratio
72.17%
Debt ratio change over timeo
-1.14%
Current Ratio
0.55%
Quick Ratio
0%
Cash Position Ratio
0.19%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
588.86%
Return on assets
-34.88%
Return on sales
0%
Return on invested capital
217.13%
Total debt ratio
111.62%
Debt ratio change over time
-1.03%
Current Ratio
0.18%
Quick Ratio
0%
Cash Position Ratio
0.13%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-94.92%
Return on assets
-100.37%
Return on sales
0%
Return on invested capital
45.88%
Total debt ratio
-50.08%
Debt ratio change over time
-0.5%
Current Ratio
-1%
Quick Ratio
0%
Cash Position Ratio
-1%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | AZRX | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -74.81% | 0% | 0% | 29.06% |
| Return on assets | -38.11% | 0% | 0% | -9.75% |
| Return on sales | 0% | 0% | 0% | -1469.44% |
| Return on invested capital | -27.08% | 0% | 0% | 47.78% |
| Profitability | 25% | 0% | 25% | 50% |
| Total debt ratio | 76.78% | 0% | 0% | 183.15% |
| Debt ratio change over time | -0.5% | 0% | 0% | 19.02% |
| Dept financing | 10% | 0% | 0% | 50% |
| Current Ratio | 0.55% | 0% | 0% | 5.9% |
| Quick Ratio | 0% | 0% | 0% | 5.9% |
| Cash Position Ratio | 0.19% | 0% | 0% | 5.68% |
| Liquididy | 12% | 0% | 0% | 75% |
| Short-term ratios | AZRX | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | 64.29% | 0% | 0% | -16.12% |
| Return on assets | -32.04% | 0% | 0% | -14.95% |
| Return on sales | 0% | 0% | 0% | -3498.94% |
| Return on invested capital | 35.2% | 0% | 0% | 96.56% |
| Profitability | 59% | 0% | 25% | 25% |
| Total debt ratio | 72.17% | 0% | 0% | 79.61% |
| Debt ratio change over time | -1.14% | 0% | 0% | 0.09% |
| Dept financing | 23% | 0% | 0% | 50% |
| Current Ratio | 0.55% | 0% | 0% | 5.9% |
| Quick Ratio | 0% | 0% | 0% | 5.9% |
| Cash Position Ratio | 0.19% | 0% | 0% | 5.68% |
| Liquididy | 3% | 0% | 0% | 75% |